Cognitive impairments in people with substance use disorders have been reliably
documented, generalizable across multiple domains and substance types. 1 Specific …

Overview Addiction to nicotine, alcohol, opioids, and other drugs is one of the leading public
health and safety challenges of our time. 1 In the United States, more than 25 million people …

ClarificationoftheDSM-5-TR1 diagnosisofcannabisuse disorder (CUD) among individuals
using cannabis for therapeutic purposes (CTP) is critical in the context of increasing …

Nearly 15 million Americans 12 years of age and older were dependent on or abused
alcohol in 2010. 1 The high prevalence of problem alcohol use worldwide has been …

As of July 2020, 11 states in the US had legalized the recreational use of cannabis and 16
others had decriminalized it, with all but 2 of the remaining 23 states allowing some form of …

Background The centuries-old term addiction remains widely used in both professional and
popular media because it communicates commonly held imagery of those whose once …

Craving has long been acknowledged by patients and clinicians as a significant feature of
substance use disorders and especially opioid use disorder (OUD), as noted in a 2018 …

Methods| Each year from 2002 to 2016, the National Survey on Drug Use and Health
(NSDUH) research staff drew a new US probability sample of noninstitutionalized civilians …

Currently, only 4 cannabis products are approved for medicinal use. However, cannabis and
cannabis products are widely promoted as therapeutic agents, placing potential burdens on …

Psychiatric neuroimaging faces ongoing challenges to establishing reproducible findings
and drawing robust inferences. 1-3 Prior standards in sample size, research design, and …